Absci (ABSI) Revenue (2020 - 2026)
Absci's Revenue was $318,000 in Q2 2026, down 46.4% from $593,000 a year earlier but up 47.9% from the prior quarter.
Absci (ABSI) Revenue (2020 - 2026) Analysis & Trends
On a trailing twelve-month basis, Absci's Revenue was $1.56 million through Jun 30, 2026, down 62.3% year-over-year; for FY2025, it came in at $2.8 million, down 38.2% from FY2024.
- Revenue has now declined for three consecutive years, with a five-year compound annual growth rate of -10.1% (FY2020 to FY2025).
- In earlier years, Revenue was $4.53 million in FY2024 (-20.7%), $5.72 million in FY2023 (-0.5%), $5.75 million in FY2022 (+20.2%) and $4.78 million in FY2021 (unchanged).
- Quarterly Revenue has moved between $215,000 (Q1 2026) and $3.37 million (Q2 2023) over five years.
- Compared with a year earlier, Revenue has declined for five straight quarters, with an average decline of 0.6% over the last eight quarters.
- The best year-over-year quarter for Revenue over five years was Q2 2023 (growth of 236.0%); the worst was Q1 2026 (a decline of 81.8%).
- Per Business Quant data, ABSI's Revenue in the three quarters before Q2 2026 was $215,000 (Q1 2026), $650,000 (Q4 2025) and $378,000 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 25.31 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 16.99 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 16.61 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 14.41 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 15.38 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 10.05 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 7.80 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 15.03 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 3.33 Bn |
| 10 | Absci | 1.63 Bn | 1.01 Bn | - | 318,000.00 |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 318,000.00 |
| Mar 31, 2026 | 215,000.00 |
| Dec 31, 2025 | 650,000.00 |
| Sep 30, 2025 | 378,000.00 |
| Jun 30, 2025 | 593,000.00 |
| Mar 31, 2025 | 1.18 Mn |
| Dec 31, 2024 | 665,000.00 |
| Sep 30, 2024 | 1.70 Mn |
| Jun 30, 2024 | 1.27 Mn |
| Mar 31, 2024 | 898,000.00 |
| Dec 31, 2023 | 338,000.00 |
| Sep 30, 2023 | 744,000.00 |
| Jun 30, 2023 | 3.37 Mn |
| Mar 31, 2023 | 1.27 Mn |
| Dec 31, 2022 | 1.56 Mn |
| Sep 30, 2022 | 2.37 Mn |
| Jun 30, 2022 | 1.00 Mn |
| Mar 31, 2022 | 819,000.00 |
| Dec 31, 2021 | 1.45 Mn |
| Sep 30, 2021 | 1.54 Mn |
Absci Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=ABSI&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "ABSI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=ABSI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();